ArticleBreast cancer research : BCR2020

ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.

Adi Zundelevich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.